Projects

• NEWTBVAC
• Pre- and early clinical development
• TBTEA
• MYCOWALC
• ADITEC
• TRANSVAC
• TBVI Advocacy & Resource Mobilisation
• TBVAC
• INYVAX
• ESI TBVI

1. TBVI »
2. Projects »
3. TBTEA

September 2011 - September 2013
765,000 euro, funded by EDCTP

TBTEA brings together European and African research organisations to improve and strengthen collaboration in TB vaccine research. Over ten institutions from both continents are connected through a platform where knowledge on clinical trials can be exchanged, where joint activities can be explored and coordinated, and where clinical trials capacity will be improved.

The 2-year project has a budget of 765,000 euros and is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) and coordinated by the Max Planck Institute for Infection Biology in Germany and TuBerculosis Vaccine Initiative (TBVI) from the Netherlands. The programme, ‘Collaboration and integration of tuberculosis vaccine trials in Europe and Africa’ (TBTEA), provides training to a number of African post-doc researchers and aims to bring together researchers to strengthen collaboration between the north and the south and to exchange knowledge and know-how. This contributes to an improved and sustainable research infrastructure in African countries where TB is a public health threat and prevents overlap and unnecessary duplication of work. European partners will benefit from better knowledge of the situation in endemic countries and will be able to make more efficient use of trial sites.

The project involves the following institutions:
Max Planck Society for the Advancement of Science, Max Planck Institute for Infection Biology, Germany
TuBerculosis Vaccine Initiative (TBVI), The Netherlands
University of Oxford, UK
Statens Serum Institute, Denmark
University of Zaragoza, Spain
INSERM, Institut Pasteur de Lille, France
South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, South Africa
Stellenbosch University, South Africa
The Infectious Diseases Institute (IDI) at Makerere University, Uganda
Armauer Hansen Research Institute (AHRI), Ethiopia
Espoir Pour La Santé (EPLS), Senegal
Hospitalier CHU Le Dantec, Senegal
Vakzine Projekt Management (VPM), Germany

 

Scientific publications:

Enabling biomarkers for tuberculosis control [State of the Art Series. New tools. Number 3 in the series]
The International Journal of Tuberculosis and Lung Disease, Volume 16, Number 9, 1 September 2012 , pp. 1140-1148(9)
Maertzdorf, J.; Weiner III, J.; Kaufmann, S. H. E.